₹301.5
-0.8 (-0.26%)
  • Advice
  • Hold
As on 22 September, 2023 | 10:54 BSE: 524735 NSE: HIKALISIN: INE475B01022

Hikal Performance

Day Range

  • Low 298.05
  • High 304.9
301.5

52 Week Range

  • Low 260.75
  • High 427.8
301.5
  • Open Price304.9
  • Previous Close302.3
  • Volume59948

Start SIP in Hikal

Start SIP

Hikal Share Price

  • Over 1 Month 6.03%
  • Over 3 Month -4.47%
  • Over 6 Month 2.12%
  • Over 1 Year -11.64%

Hikal Key Statistics

P/E Ratio 39.5
PEG Ratio -5.8
Market Cap Cr 3,718
Price to Book Ratio 3.3
EPS 6.3
Dividend 0.4
Relative Strength Index 50.95
Money Flow Index 64.53
MACD Signal 3.08
Average True Range 8.55

Hikal Investment Rating

  • Master Rating:
  • Hikal has an operating revenue of Rs. 2,032.29 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of 5% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 43%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 83 which is a GOOD score indicating consistency in earnings, a RS Rating of 16 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 99 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Hikal Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 388538538557371501
Operating Expenses Qtr Cr 338457466489356441
Operating Profit Qtr Cr 508875702361
Depreciation Qtr Cr 282728272724
Interest Qtr Cr 14131311118
Tax Qtr Cr 31398-38
Net Profit Qtr Cr 7362625-921
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 2,0281,948
Operating Expenses Annual Cr 1,7661,602
Operating Profit Annual in Cr 257341
Depreciation Cr 10996
Interest Annual Cr 4831
Tax Annual Cr 2758
Net Profit Annual Cr 78161
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 294
Cash from Investing Activity Annual Cr -284
Cash from Financing Annual Activity Cr -6
Net Cash Flow Annual Cr 4
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,1331,068
Fixed Assets Annual Cr 1,3601,174
Total Non Current Assets Annual Cr 1,4461,249
Total Current Assets Annual Cr 939964
Total Assets Annual Cr 2,3852,213
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 9287
ROE Annual % 715
ROCE Annual % 917
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1318
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 386538538557371501
Operating Expenses Qtr Cr 338457466489356441
Operating Profit Qtr Cr 508875702361
Depreciation Qtr Cr 282728272724
Interest Qtr Cr 14131311118
Tax Qtr Cr 31398-38
Net Profit Qtr Cr 7362625-921
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 2,0281,948
Operating Expenses Annual Cr 1,7661,602
Operating Profit Annual in Cr 257341
Depreciation Cr 10996
Interest Annual Cr 4831
Tax Annual Cr 2758
Net Profit Annual Cr 78160
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 294
Cash from Investing Activity Annual Cr -284
Cash from Financing Annual Activity Cr -6
Net Cash Flow Annual Cr 4
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,1331,068
Fixed Assets Annual Cr 1,3601,174
Total Non Current Assets Annual Cr 1,4461,249
Total Current Assets Annual Cr 939964
Total Assets Annual Cr 2,3852,213
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 9287
ROE Annual % 715
ROCE Annual % 917
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1318

Hikal Technicals

EMA & SMA

Current Price
₹301.5
-0.8 (-0.26%)
  • Bullish Moving Average
  • ___
  • 6
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • ₹302.46
  • 50 Day
  • ₹300.15
  • 100 Day
  • ₹302.79
  • 200 Day
  • ₹312.73
  • 20 Day
  • ₹302.23
  • 50 Day
  • ₹296.4
  • 100 Day
  • ₹301.47
  • 200 Day
  • ₹318.5

Hikal Resistance and Support

PIVOT
₹303.86
Resistance
First Resistance ₹307.2
Second Resistance ₹312.11
Third Resistance ₹315.45
RSI 50.95
MFI 64.53
MACD Single Line 3.08
MACD 2.92
Support
First Resistance ₹298.95
Second Resistance ₹295.61
Third Resistance ₹290.7

Hikal Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 171,843 7,298,172 42.47
Week 271,965 11,922,935 43.84
1 Month 415,734 19,007,367 45.72
6 Month 433,573 16,657,880 38.42

Hikal Result Highlights

Hikal Synopsis

NSE-Medical-Diversified

Hikal Ltd. is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 2023.03 Cr. and Equity Capital is Rs. 24.66 Cr. for the Year ended 31/03/2023. Hikal Ltd. is a Public Limited Listed company incorporated on 08/07/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1988PTC048028 and registration number is 048028.
Market Cap 3,712
Sales 2,032
Shares in Float 3.82
No of funds 69
Yield 0.4
Book Value 3.29
U/D Vol ratio 1.1
LTDebt / Equity 43
Alpha -0.03
Beta 1.04

Hikal

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 68.85%68.85%68.83%68.77%
Mutual Funds 2.39%1.79%1.3%1.1%
Insurance Companies 0.12%0.12%0.12%0.12%
Foreign Portfolio Investors 4.57%4.56%4.4%4.27%
Individual Investors 18.56%18.72%18.78%19.2%
Others 5.51%5.96%6.57%6.54%

Hikal Management

Name Designation
Mr. Jai Hiremath Executive Chairman
Mr. Sameer Hiremath Managing Director
Ms. Sugandha Hiremath Director
Mrs. Shivani Bhasin Sachdeva Director
Mr. Ranjit Shahani Director
Mr. Kannan Unni Director
Mr. Amit Kalyani Director
Mr. Baba Kalyani Director
Mr. Prakash Mehta Director
Mr. Shrikrishna Adivarekar Director

Hikal Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Hikal Corporate Action

Date Purpose Remarks
2023-08-08 Quarterly Results
2023-05-29 Audited Results & Final Dividend
2023-02-02 Quarterly Results & Interim Dividend
2022-11-09 Quarterly Results
2022-08-10 Quarterly Results
Date Purpose Remarks
2023-02-14 INTERIM Rs.0.60 per share(30%)Interim Dividend
2022-09-15 FINAL Rs.0.40 per share(20%)Final Dividend
2022-02-24 INTERIM Rs.1.20 per share(60%)Interim Dividend
2021-08-26 FINAL Rs.1.00 per share(50%)Final Dividend
2021-02-16 INTERIM Rs.1.00 per share(50%)Interim Dividend

Hikal MF Shareholding

Name Amount(cr)
Tata Small Cap Fund Regular Growth 6015
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 657
Motilal Oswal Nifty 500 Fund Regular Growth 524
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 422
SBI Nifty Smallcap 250 Index Fund Regular Growth 281
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Hikal FAQs

What is Share Price of Hikal ?

Hikal share price is ₹301 As on 22 September, 2023 | 10:40

What is the Market Cap of Hikal ?

The Market Cap of Hikal is ₹3717.5 Cr As on 22 September, 2023 | 10:40

What is the P/E ratio of Hikal ?

The P/E ratio of Hikal is 39.5 As on 22 September, 2023 | 10:40

What is the PB ratio of Hikal ?

The PB ratio of Hikal is 3.3 As on 22 September, 2023 | 10:40

Q2FY23